Package 62135-790-12

Brand: ethosuximide

Generic: ethosuximide
NDC Package

Package Facts

Identity

Package NDC 62135-790-12
Digits Only 6213579012
Product NDC 62135-790
Product ID 62135-790_24119078-bcee-0aa9-e063-6394a90af9c8
Description

120 CAPSULE in 1 BOTTLE (62135-790-12)

Marketing

Marketing Status
Marketed Since 2023-10-23
Brand ethosuximide
Generic ethosuximide
Sample Package No

Linked Drug Pages (1)

ETHOSUXIMIDE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "24119078-bcee-0aa9-e063-6394a90af9c8", "openfda": {"nui": ["N0000175753", "N0000008486"], "upc": ["0362135790127"], "unii": ["5SEH9X1D1D"], "rxcui": ["197682"], "spl_set_id": ["43fdfd16-c723-452a-9c1d-accf6f7c622e"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 CAPSULE in 1 BOTTLE (62135-790-12)", "package_ndc": "62135-790-12", "marketing_start_date": "20231023"}], "brand_name": "ETHOSUXIMIDE", "product_id": "62135-790_24119078-bcee-0aa9-e063-6394a90af9c8", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62135-790", "generic_name": "ETHOSUXIMIDE", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ETHOSUXIMIDE", "active_ingredients": [{"name": "ETHOSUXIMIDE", "strength": "250 mg/1"}], "application_number": "ANDA200892", "marketing_category": "ANDA", "marketing_start_date": "20150909", "listing_expiration_date": "20261231"}